News
A collaborative effort between Guardant Health, Blueprint Medicines and Winship Cancer Institute, the study analyzed de-identified clinical and genomic data using the GuardantINFORM real-world ...
Leveraging AI to help analyze and visualize data gathered from a variety of data sets enables data-driven insights and fast analysis without the high costs of talent and technology. In today's ...
Novo Nordisk’s Wegovy cut the risk of severe complications in patients with a common form of heart failure, according to a new analysis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results